Literature DB >> 26293577

Observation of risk factors, clinical manifestations and genetic characterization of recent Newcastle Disease Virus outbreak in West Malaysia.

Seetha Jaganathan1,2,3, Peck Toung Ooi4, Lai Yee Phang5, Zeenathul Nazariah Binti Allaudin6, Lai Siong Yip7, Pow Yoon Choo8, Ban Keong Lim9, Stephane Lemiere10, Jean-Christophe Audonnet11.   

Abstract

BACKGROUND: Newcastle disease virus remains a constant threat in commercial poultry farms despite intensive vaccination programs. Outbreaks attributed to ND can escalate and spread across farms and states contributing to major economic loss in poultry farms.
RESULTS: Phylogenetic analysis in our study showed that eleven of the samples belonged to genotype VIId. All farms were concurrently positive with two immunosuppressive viruses; Infectious Bursal Disease Virus (IBDV) and Marek's Disease Virus (MDV). Amino acid sequence analysis confirmed that eleven of the samples had sequence motifs for velogenic/mesogenic strains; three were lentogenic.
CONCLUSION: In conclusion, no new NDV genotype was isolated from the 2011 NDV outbreak. This study suggests that the presence of other immunosuppressive agents such as IBD and MDV could have contributed to the dysfunction of the immune system of the chickens, causing severe NDV outbreaks in 2011. Risk factors related to biosecurity and farm practices appear to have a significant role in the severity of the disease observed in affected farms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26293577      PMCID: PMC4546084          DOI: 10.1186/s12917-015-0537-z

Source DB:  PubMed          Journal:  BMC Vet Res        ISSN: 1746-6148            Impact factor:   2.741


Background

Newcastle disease (ND) is a highly contagious viral disease in domestic poultry, aviary and wild birds. Despite intensive vaccination programs, the virus remains a constant threat to the commercial poultry farms in Malaysia [1]. The disease is classified in the World Organization for Animal Health (OIE) as a notifiable disease (formerly list A) [2, 3]. It is a member of the order Mononegavirales, family Paramyxoviridae and genus Avulavirus with an enveloped virus which has a negative-sense, non-segmented single-stranded RNA genome consisting of 15,586 nucleotides [4]. Its genome comprises six genes: nucleoprotein (NP), phosphoprotein (P), matrix protein (M), fusion glycoprotein (F), hemagglutinin-neuraminidase (HN) glycoprotein and large polymerase protein (L). Of the 6 genes found in NDV, its two membrane proteins, the F gene and the HN gene are most important in determination of its virulence. The fusion (F) protein is responsible in mediating fusion of the viral envelope with cellular membranes and the haemagglutinin-neuraminidase (HN) protein is involved in cell attachment and release [4-6]. Newcastle disease virus strains are classified into 3 pathotypes, highly virulent (velogenic), intermediate (mesogenic) or non-virulent (lentogenic) [7]. Traditionally, NDV pathotypes are most commonly distinguished by nucleotide sequencing. The consensus sequence of the F protein cleavage site of velogenic and mesogenic strains is 112(R/K)RQ(R/K)RF117; the consensus sequence of the lentogenic F cleavage site is 112(G/E)(K/R)Q(G/E)RL117 [7, 8]. A recent finding documented that a change of glutamine to basic residue arginine (R) at position 114 of the F cleavage site reduced the viral replication and attenuated the virus pathogenicity. The paper also reported that the pathogenicity was further reduced when isoleucine (I) at position 118 was substituted by valine [9]. NDV isolates have been classified into lineages or genotypes based on the analysis of the fusion (F) gene. Aldous et al. 2003 initially used the lineage classification system which grouped NDV isolates into six lineages (1–7) and 13 sub-lineages. Another lineage (lineage 7) and seven other sub-lineages were later proposed. Another classification for NDV classifies the virus into two major groups called class I and class II. There are nine genotypes (1–9) in Class I and eleven genotypes (I-XI) in Class II (2) with genotypes I, II, VI, and VII being further divided into sub-genotypes 1a and 1b, II and IIa, VIa through VIf and VIIa through VIIh [10-13]. Genotype I consists of the avirulent strains of NDV, while viruses of genotypes II, III and IV were reported to be responsible for the first panzootics before the 1960s [10]. Genotype V was thought to be responsible for the second panzootics in the early 1970s and genotype VII viruses caused the third panzootics in racing pigeons during the 1980s [4, 6, 8, 14–21]. Severe outbreaks in Western Europe, South Africa and Southern Europe, Taiwan and China since the early 1990s have been caused by the prevalent genotype VII (VIIa-VIId), constituting the fourth panzootic of NDV [14–16, 18, 22]. Genotype VIII has been found to cause enzootic infections in Southern Africa and is believed to have originated from the Far East [15]. Genotype IX of the ND virus has caused sporadic NDV infections in some regions of China [2, 19], whereas Tsai et al. first demonstrated novel genotype X viruses in Taiwan [18, 21, 23, 24]. The clinical signs and pathological lesions of ND vary with the age and species of birds, the immune status of the host and environmental conditions. A very high number of NDV cases with high mortality in broilers and lower prevalence in layers, breeders and native broilers were reported by field veterinarians towards the end of 2010 through 2011 in Malaysia. Newcastle disease virus infection was suggested as the tentative diagnosis on the basis of history, clinical syndrome, gross lesions, serology as well as isolation of NDV, or the presence of NDV by PCR and/or molecular characterization of the fusion protein gene. These cases were reported in farms which had various combinations of primary and booster vaccinations with lentogenic as well as mesogenic NDV vaccine, or inactivated NDV vaccines. Though vaccinated with NDV vaccines, some of the chicken farms were totally wiped out. Various hypotheses were raised to explain the occurrences of the disease which included 1) a change in pathogenicity of ND virus, 2) vaccine and vaccination practices, and 3) concurrent infection with other immunosuppression organisms or presence of other non-infectious agents. Previous studies have demonstrated the presence of genotype VII and genotype II in Malaysia from 2004 until 2010 [1, 20, 25]. Here we will describe the genetic characterization of the recent isolates from the 2011 NDV outbreaks in West Malaysia with the objective of assessing the risk factors associated with the disease in affected farms. This will investigate the presence of IBDV and MDV as possible immunosuppressive agent, and to determine if there are any new NDV genotype in the 2011 outbreak cases.

Methods

Animals ethics

All samples were collected under the supervision of institution veterinarians. The study was conducted following the guidelines as stated in the Code of Practice for Care and use of Animals for Scientific Purposes as stipulated by Universiti Putra Malaysia and complied with the current guidelines for the care and use of animals and was approved by the Institutional Animal Care and Use Committee (IACUC), Faculty of Veterinary Medicine, Universiti Putra Malaysia. There was no experimental research done on the animals. No animals were deliberately sacrificed or injured during the sampling procedure. Every effort was made to minimize any distress or unnecessary culling.

Sampling

Organ samples were collected from twelve broiler farms displaying typical clinical signs for ND (Fig. 1) in various states in West Malaysia. Five sick birds per farm were sacrificed for the collection of specimens (trachea, lung, spleen, caecal tonsils, proventriculus, intestine, brain, liver, kidney, lymph nodes, bone marrow and bursal of Fabricius). Two farms from East Malaysia with no clinical ND infection were included into the study as negative control.
Fig. 1

Clinical signs observed from the outbreak. a A typical torticollis is shown. These symptoms normally occur 7 to 10 days after a complaint of high mortality is reported. b In severely affected birds, mild swollen head and dyspnea with profuse secretions in the trachea were found. c & d Hemorrhagic & necrosis of intestines especially the caecal tonsils & peyer’s patches were found. e Upon PM, the trachea was severely congested and late in the disease stages pericarditis, perihepatitis and caseous air sacculitis were observed. f Proventicular hemorrhages were consistent. g, h & i Bursa atrophy was also commonly found in the outbreak. The cut surfaces of the bursa were hemorrhagic – quite atypical from ND infection which prompted us to look for other infectious agents. Not shown above was atrophic thymus

Clinical signs observed from the outbreak. a A typical torticollis is shown. These symptoms normally occur 7 to 10 days after a complaint of high mortality is reported. b In severely affected birds, mild swollen head and dyspnea with profuse secretions in the trachea were found. c & d Hemorrhagic & necrosis of intestines especially the caecal tonsils & peyer’s patches were found. e Upon PM, the trachea was severely congested and late in the disease stages pericarditis, perihepatitis and caseous air sacculitis were observed. f Proventicular hemorrhages were consistent. g, h & i Bursa atrophy was also commonly found in the outbreak. The cut surfaces of the bursa were hemorrhagic – quite atypical from ND infection which prompted us to look for other infectious agents. Not shown above was atrophic thymus Consent was obtained from all farm owners for the harvesting of chicken organ samples from their farms.

Observation of risk factors and clinical manifestation

A standardized survey was used to assess risk factors associated with the high mortality observed. The survey covered the following parameters 1) flock characteristics, 2) vaccination programs, 3) mortality and morbidity rates, 4) age of occurrence, clinical and necropsy lesions and 5) farm management factors such as single/multi age farming practices, source of day old chick (DOC), breed of broilers, number of houses affected, stocking density, disease in neighboring farm, previous history of poor performance/mortality, measures taken in outbreak, measures taken after outbreak for next cycle and performance of the next 2 grow-outs after first incidence. A scoring system (1–5) with 1 (poor) to 5 (very good) was used to evaluate the biosecurity and disinfection status of farms. The data was compiled and analyzed using t-test, chi (χ)2 and appropriate statistical tests to compare with the negative controls.

Serology

Serum samples were collected from only four farms from vaccinated flocks (25–40 days), as the study was conducted from commercial production farms with current ND outbreaks. It was not possible to obtain paired serum samples for comparison from every farm as the severity of the outbreak caused very high mortality. The ND-HI titer analysis was conducted by Vet Food Agro Diagnostics (M) Sdn. Bhd.

Screening of NDV, IBD, MDV

Organ samples were pooled for screening by real-time PCR for NDV and for other immunosuppressive agents i.e., MDV and IBDV. The organ samples were subjected to nucleic acid extraction by using the Trizol LS reagent (Invitrogen, USA) following the standard manufacturer’s protocol. The real time PCR was established from methods previously described [1, 26, 27]. The real time PCR mixtures consisted of 10 μl of SYBR green master mix, the respective primer sets and PCR grade water to make up the final volume of 20 μl per reaction. The PCR mixtures were subjected to real time PCR amplification in a 384-well microplate in the LC480 Real Time PCR instrument (LC 480, Roche). The melting peaks and melting curves were observed by using the Absolute Quant Software provided with the instrument. The respective primer sets are as follow, NDV primers specific for the fusion protein gene, 5′-ATG GGC(C/T) CCA GA(C/T) CTT CTA C-3′ (forward) and 5′-CTG CCA CTG CTA GTT GTG ATA ATC C-3′ (reverse) (Amplicon size: 545 bp); IBD primers, 5′-GT RAC RAT CAC ACT GTT CTC AGC-3′ (Y=C/T); (R=A/G) (forward) and 5′-GAT GTR AYT GGC TGG GTT ATC TC-3′ (reverse) (Amplicon size: 248 bp); MDV-serotype 1 primers, 5′-GAC TCG CTC GCA CAT C-3′ (forward) and 3′-CGA CAC TCC GCA GTT-5′ (reverse) (Amplicon size: 102 bp); MDV-serotype 2 primers; 5′-GTT TCG TCT ACC ACC CG-3′ (forward) and 5′-ATG CCA CTG TAT TTG ATC TCC-3′ (reverse) (Amplicon size: 139 bp); MDV-serotype 3 primers, 5′-ACC GCA ACT CTT CTC ACA-3′ (forward) and 3′-CTC GGG CAA CCT CTA CAT-5′ (reverse) (Amplicon size: 201 bp). Primer sets for MDV serotype 1, 2 and 3 were designed by using the Primer Premier 5 software from Premier Biosoft.

Sequencing, amino acid sequence analysis, phylogenetic construction of NDV from the 2011 outbreak

The same primer sets for amplifying NDV as described above [1, 26] were used for sequencing. The PCR products of the expected amplicon sizes were purified by using the PCR clean-up gel extraction kit according to the manufacturer’s protocol with slight modifications (Analytik Jena, Germany). Sequencing of the fusion protein gene of NDV from the 14 farms was done in a commercial sequencing facility using the BigDye® Terminator v3.1 cycle sequencing kit. In order to confirm that all positive cases were true Newcastle disease virus, a Basic Local Alignment Search Tool (BLAST) search of the sequence was done in the Genbank® database (Data not shown). The sequence editing and assembly were done by using BioEdit® Sequence Alignment Editor version 7.0.5.2 (Tom Hall, US). Sequences were aligned by using ClustalX™. The phylogenetic tree was constructed by using the distance-based neighbor joining method by using Mega™ 5 software (Biodesign Institute, Tempe, Arizona) and evaluated using the bootstrapping method calculated on 1000 repeats of the alignment. The sequence identity matrix was generated with BioEdit® Sequence Alignment Editor version 7.0.5.2 (Tom Hall, US). All sequences used for constructing the phylogenetic tree are listed in Table 1.
Table 1

NDV isolates derived from this study and other isolates reported previously

NoIsolate nameGenbank® accession numberGenotypeCountryReference
1V4 QueenslandM24693IAustraliaGenbank®
2Ulster/67M24694IN. IrelandGenbank®
3F7JN613118IMalaysiaThis study
4LasotaM24696IIUSAGenbank®
5MB061/07GQ901891IIMalaysiaGenbank®
6F5JN613116IIMalaysiaGenbank®
7F6JN613117IIMalaysiaGenbank®
8MiyaderaM24701IIIJapanGenbank®
9ItalienEU293914IVItalyGenbank®
10Herts/33AY741404IVUKGenbank®
11CA1085/71AF001106VUSAGenbank®
12H-10/72AF001107VHungaryGenbank®
13TX3503/04EU477190VIUSAGenbank®
14NDV05-027DQ439885VIChinaGenbank®
15Q-GB 506/97AF109887VIUKGenbank®
16DK-1/95AF001129VIDenmarkGenbank®
17Iraq AG68AF001108VIIraqGenbank®
18Lebanon-70AF001110VILebanonGenbank®
19MB047/05GQ901895VIIaMalaysiaGenbank®
20Cockatoo/14698/90AY288998VIIaIndonesiaGenbank®
21ZA360/95AF109876VIIbS. AfricaGenbank®
22ZW3422/95AF109877VIIbZimbabweGenbank®
23NDV05-055DQ439910VIIcChinaGenbank®
24TW/2000AF358786VIIc/dTaiwanGenbank®
25F8JN613119VIIdMalaysiaGenbank®
26Ch/2000AF358788VIIdChinaGenbank®
27MB064/05GQ901893VIIdMalaysiaGenbank®
28MB016/07GQ901894VIIdMalaysiaGenbank®
29F1JN613112VIIdMalaysiaThis study
30F2JN613113VIIdMalaysiaThis study
31F3JN613114VIIdMalaysiaThis study
32F4JN613115VIIdMalaysiaThis study
33F9JN613120VIIdMalaysiaThis study
34F10JN613121VIIdMalaysiaThis study
35F11JN613122VIIdMalaysiaThis study
36F12JN613123VIIdMalaysiaThis study
37F13JN613124VIIdMalaysiaThis study
38F14JN613125VIIdMalaysiaThis study
39MB043/06GQ901896VIIdMalaysiaGenbank®
40MB091/05FJ008916VIIdMalaysiaGenbank®
41MB093/05FJ008917VIIdMalaysiaGenbank®
42MB095/05FJ008918VIIdMalaysiaGenbank®
43MB128/04FJ008923VIIdMalaysiaGenbank®
44DE143/95AF109881VIIdUKGenbank®
45TW/95-1AF083960VIIeTaiwanGenbank®
46MB076/05GQ901892VIIeMalaysiaGenbank®
47AF2240AF048763VIIIMalaysiaGenbank®
48MB085/05GQ901901VIIIMalaysiaGenbank®
49QH-1/79AF378250VIIIChinaGenbank®
50QH-4/85AF378252VIIIMalaysiaGenbank®
51ZhJ-1/85AF458023IXMalaysiaGenbank®
52FJ-1/85AF458009IXMalaysiaGenbank®
NDV isolates derived from this study and other isolates reported previously

Results & discussion

Observation of risk factors and clinical manifestations

The results of the survey are shown in Tables 2, 3, 4 and 5. Table 2 describes farm characteristics and type of breeds used. All farms were multi-age broiler farms stocked with various commercial breeds namely Cobb, Ross or commercial native birds. The mean flock population was about 90,000 broilers (83.3 % of houses were open sided houses). On average, 7.2 houses were affected. Over 90 % of the farms surveyed were located within 1 km radius to other broiler and reported high mortality in neighboring farms. More than 50 % of the farms had poor performance in its two previous grow-outs (P < 0.05), reported that the day-old-chick quality were poor in the affected flock (P < 0.01) and had unsubstantiated evidence that the chicks were sourced from breeder flocks which had been reported with high mortalities resembling ND (P < 0.05). The average age of onset of disease was 15.9 (P < 0.05) days old which was reported to be at the time or after IBD vaccinations were administered and 28 days in the negative control farms.
Table 2

Comparison of serology titer from the surveyed ND outbreak vs. serology titer from non-survey farms ND outbreak

GMTMean
Farm 6 (survey)ND outbreak with IBD and MD detected1.51.8
Farm 4, 7, 8 (survey)ND outbreak with IBD and MD detected212.8390.4
Table 3

Farm characteristics and history

Risk factorAffected farmsNegative controls
No of farms122
Number of broilers per farm89,950a 87,500a
Number of houses per farm11.1a 6.5a
Number of houses affected per farm7.2a 1.5a
Type of management – multi-ageMulti-ageMulti-age
Type of housing – open-sided housingOpenOpen
Farms within 1 km of affected farm92 %a 50 %a
Poor performance in the last 2 grow outs50 %c 0 %d
Neighboring farms with history of disease91.7 %a 0 %b
Complaints of poor day-old-chick quality50 %c 50 %d
Disease after IBD vaccination or about Week 2-383.3 %a 50 %b
Suspected source of chicks from breeder farms with disease66.7 %a 0 %b

Note: a,bValues in different columns bearing different superscripts are significantly different (P < 0.05), c,dValues in different columns bearing different superscripts are significantly different (P < 0.01)

Table 4

Vaccination and assessment of biosecurity and sanitation status

Risk factorAffected farmsNegative controls
Biosecurity status1.7a 2.5a
Sanitation and disinfection status2.6a 2.5a
Vaccination with NDv100 %a 100 %a
Vaccination with IBv100 %a 100 %a
Vaccination with IBDv91.7 %a 91.7 %a
Vaccination with MDv8.3 %a 0 %b
Vaccination with SHSv8.3 %a 0 %b

Note: a,bValues in different columns bearing different superscripts are significantly different (P < 0.05), c,dValues in different columns bearing different superscripts are significantly different (P < 0.01)

Table 5

Zootechnical results, clinical and necropsy findings

Risk factorAffected farmsNegative controls
Age of first occurrence of disease15.9a 28.0a
Age of clinical and necropsy examination24.8a 32.5a
Mortality at grow-out, %32.3 %a 4.5 %b
Presence of respiratory disease100 %a 100 %a
Presence of enteric disease100 %a 0 %b
Torticolis and neurological signs91.7 %a 0 %b
Haemorrhages in more than 1 visceral organ83.3 %a 0 %b
Thymus atrophy100 %a 0 %b
Bursal atrophy75 %a 50 %b
Ascites8.3 %a 50 %a
Air-sacculitis, perihepatitis and peritonitis16.7 %a 50 %b
Clouded air sacs50 %c 100 %d

Note: a,bValues in different columns bearing different superscripts are significantly different (P < 0.05), c,dValues in different columns bearing different superscripts are significantly different (P < 0.01)

Comparison of serology titer from the surveyed ND outbreak vs. serology titer from non-survey farms ND outbreak Farm characteristics and history Note: a,bValues in different columns bearing different superscripts are significantly different (P < 0.05), c,dValues in different columns bearing different superscripts are significantly different (P < 0.01) Vaccination and assessment of biosecurity and sanitation status Note: a,bValues in different columns bearing different superscripts are significantly different (P < 0.05), c,dValues in different columns bearing different superscripts are significantly different (P < 0.01) Zootechnical results, clinical and necropsy findings Note: a,bValues in different columns bearing different superscripts are significantly different (P < 0.05), c,dValues in different columns bearing different superscripts are significantly different (P < 0.01) The frequency of vaccination in the 12 study farms for Newcastle disease, Infectious Bronchitis, Infectious Bursal disease, Marek’s disease and Swollen Head Syndrome (SHS); a disease caused by Avian metapneumovirus; were 100 %, 100 %, 91.7 %, 8.3 % and 8.3 % respectively (Table 4). The frequency of ND vaccination for lentogenic, mesogenic and inactivated vaccines were 100 %, 33.3 % and 50.0 % with all farms practicing multiple ND vaccinations in the lifecycle of the broilers. Biosecurity and farm sanitation scores were 1.7 and 2.6 respectively. The onset of clinical ‘ND’ disease was reported at 15.9 days old (P < 0.05) with a final grow out mortality of affected flocks at 32.3 % (P < 0.05) (Table 5). All the farms initiated treatment with antimicrobials and supportive treatments (vitamins and electrolyte) and upgraded sanitation and disinfection practices when the disease was observed or when advised by field veterinarians. The primary clinical signs were inappetance, depression, ruffled feathers, whitish to greenish and watery diarrheoa, head swelling and dyspnoea. Torticollis was seen at about 7–10 days after the onset of clinical signs. Gross pathology lesions included profuse fluids in the trachea and bronchus, congested trachea, gizzard and proventricular erosions and hemorrhages, hemorrhages on Peyer’s patches and caecal tonsils and in other visceral organs. Bursa (P < 0.05) and thymus atrophy were present in the majority of cases. The disease process appeared to be of acute onset with significantly reduced observations of air sacculitis, perihepatitis and peritonitis (P < 0.05). NDV, IBDV and MDV were detected in organs and tissues at 100 %, 83 % and 83 % respectively by PCR, with MD Serotypes 2, 1 and 3 in descending order of detection. NDV, IBDV and MDV were detected concurrently in 75 % of farms (Table 6). The concurrent presence of IBDV and MDV with NDV were significant at P < 0.05 and with the presence of MDV Serotype 1 (P < 0.01).
Table 6

Detection of infectious agents concurrently with NDV positive samples

Presence of concurrent infectious agent in disease farmsFrequency of detection
IBD83.0 %
MD83.0 %
IBD+MD75.0 %
MD Serotype 158.0 %
MD Serotype 275.0 %
MD Serotype 367.0 %
Detection of infectious agents concurrently with NDV positive samples Serology results from one farm (Farm 6) showed that the antibody titer was low and not as expected with a mean titer of 1.8. Antibody titer from three other farms (Farm 4, 7 and 8) was very high for a broiler which indicates that there’s an infection.

Screening for NDV, IBD and MDV

Samples from all farms were found to be positive for NDV, IBD and MDV, and clearly evident that immunosupression continues to be a major problem for the poultry industry. IBDV is one of the most common immunosuppressive agents in poultry. It primarily targets the bursa of Fabricious which is committed to the differentiation and proliferation of B-lymphocytes into antibody-producing plasma cells. In the bursa, IBDV produces severe destruction of B-lymphocytes by either necrosis or apoptosis, and consequently the antibody-mediated response (humoral) is affected [27, 28]. Recent studies have also demonstrated that this virus can also hinder some of the mechanisms of cellular immunity making chickens more susceptible to viral respiratory infections and elevating mortality. Thus, the immune response to vaccines is impaired and the overall productive performance may be significantly decreased in all types of chickens. Similarly, Marek’s Disease, which is an ubiquitous, complex, lymphoproliferative disease of chickens caused by a strong cell-associated alpha herpesvirus, MD virus (MDV) is progressive in nature with a relatively long incubation period and the virulent virus can remain in the host without producing any clinical syndromes [23, 24, 29, 30]. The primary cell targets of MDV infection are lymphocytes, and as a result, early effects are mainly seen in lymphoid organs such as the bursa of Fabricius (source of B lymphocytes), the thymus (primary source of T lymphocytes) and the spleen. Consequences of these MDV-induced immunosuppresion have also shown to cause reduced resistance to other concurrent infections [29-31]. Therefore, based on the findings, the presence of IBD and MDV suggest a significant negative impact on the immune system and growth of these broiler chickens. NDV itself was not immunosuppressive, and vaccination with killed-NDV vaccines failed to reduce incidences of NDV outbreaks, because the core underlying factors such as IBD and MDV that were causing sub-clinical infections were not addressed, thus reducing the protective effect of the NDV vaccination programs.

Sequencing, amino acid sequence analysis, phylogenetic construction

BLAST® analysis showed that all samples were true NDV cases when compared with other sequences on Genbank®. Amino acid sequence analysis of the 535 bp fragment of the fusion protein (F) gene of the fourteen Malaysian NDV isolates showed that eleven of the isolates were categorized as velogenic virus and three were lentogenic. The eleven velogenic strain had the F cleavage site motif 112R-R-R-K-R-F117 while two of the lentogenic strain had the F cleavage site motif 112G-R-Q-G-R-L117, whilst one sequence had the F cleavage site motif 112G-K-Q-G-R-L117 at the C-terminus of the F2 protein and phenylalanine (F) residue at amino acid position 117 of the N-terminus of the F1 protein (Table 7). Phylogenetic analysis revealed that 11 of the Malaysian isolates clustered closely with the genotype VIId strains, one of the Malaysian isolate grouped together with genotype I and two of the isolates grouped with genotype II (Fig. 2). Of the eleven Malaysian isolates that grouped to form genotype VIId, ten (F1, F2, F3, F4, F9, F10, F11, F12, F13, F14) had between 97.9 to 98.7 % sequence identity similarities with other Malaysian isolates responsible for the Newcastle disease outbreaks in 2004–2005 and 2007 which were previously reported by researchers from Universiti Putra Malaysia [20, 28, 31]. All these isolates have between 91 and 92 % similarities with the Indonesian strain (cockatoo/14698/90). One (F8) of the Malaysian isolate which grouped with genotype VIId had 96.1 % similarities with the China strain (Ch/2000). Of the three lentogenic strains isolated from this study, two (F5, F6) had between 97.4 and 97.5 % nucleotide sequence similarities with genotype II while one isolate (F7) had around 88.8 % nucleotide sequence similarities with genotype I.
Table 7

The F cleavage site and it’s pathotypes from the Malaysian isolates

IsolateGenbank® accession noF cleavage siteGenotypePathotypeSource
F1JN613112RRRKRFVIIdVelogenic/MesogenicThis study
F2JN613113RRRKRFVIIdVelogenic/MesogenicThis study
F3JN613114RRRKRFVIIdVelogenic/MesogenicThis study
F4JN613115RRRKRFVIIdVelogenic/MesogenicThis study
F5JN613116GRQGRLIILentogenicThis study
F6JN613117GRQGRLIILentogenicThis study
F7JN613118GKQGRLILentogenicThis study
F8JN613119RRRKRFVIIdVelogenic/MesogenicThis study
F9JN613120RRRKRFVIIdVelogenic/MesogenicThis study
F10JN613121RRRKRFVIIdVelogenic/MesogenicThis study
F11JN613122RRRKRFVIIdVelogenic/MesogenicThis study
F12JN613123RRRKRFVIIdVelogenic/MesogenicThis study
F13JN613124RRRKRFVIIdVelogenic/MesogenicThis study
F14JN613125RRRKRFVIIdVelogenic/MesogenicThis study
Fig. 2

Phylogenetic Tree constructed with 52 NDV sequences obtained from this study and Genbank®. The tree was designed by using the neighbour-joining method on Mega 5. The sequences from this study are indicated by the diamond shaped symbol

The F cleavage site and it’s pathotypes from the Malaysian isolates Phylogenetic Tree constructed with 52 NDV sequences obtained from this study and Genbank®. The tree was designed by using the neighbour-joining method on Mega 5. The sequences from this study are indicated by the diamond shaped symbol Overall, based on the amino acid sequence analysis, eleven of the farms displayed the typical sequence motifs for velogenic/mesogenic, while three had the sequence motif for lentogenic strains. This correlates with the fact that two of the samples (F6 & F7) were collected as negative controls from farms with no mortality. Based on phylogenetic investigations, eleven (F1, F2, F3, F4, F8, F9, F10, F11, F12, F13, F14) of the samples clustered with the genotype VIId and had a very close relationship with the previously isolated Malaysian isolates (MB043/06, MB091/06, MB093/05, MB095/05, MB128/04) which suggest that similar NDV strains have been circulating in this region for several years now [1, 20, 25].

Nucleotide sequence accession numbers

The complete genomic sequences of the 14 NDV isolates reported in this paper were deposited with the GenBank® database under accession numbers JN613112, JN613113, JN613114, JN613115, JN613116, JN613117, JN613118, JN613119, JN613120, JN613121, JN613122, JN613123, JN613124 and JN613125. These sequences are downloadable from Entrez™ Pop Set data as a group of sequences.

Conclusion

The present study confirms that similar velogenic NDV genotype VIId, as reported previously, were detected in the study farms in spite of vaccination. In addition, no new genotype of ND virus was found based on the genetic characterization. IBDV and MDV were also concurrently detected by PCR. Immunosuppressive agents play a significant role in vaccination failures. However, the role, interactions and effect of these immunosuppressive agents as well as other concurrent infectious and non infectious agents not studied in the disease process could not be fully ascertained. Risk factors such as multi-age production practices, close proximity of farms, biosecurity and sanitation practices appear to have a role in the outcome of the disease, in terms of severity, mortality, clinical and pathological findings. Preventive measures taken post outbreak such as improved biosecurity and sanitation appear to have mediated improved performance in subsequent grow-outs. The findings from this study suggest that there may not be a need for a new vaccine as the same genotype that has been present for a long time is still responsible for the current ND outbreaks. Further to that, the findings also suggest that risk factors related to biosecurity and farm practices appear to have a significant role in the severity of the disease observed in affected farms. If those factors are alleviated, the severity of the ND problems in farms would be greatly reduced.
  26 in total

1.  Antigenic and genotypical characterization of Newcastle disease viruses isolated in Taiwan between 1969 and 1996.

Authors:  Hsiang-Jung Tsai; Kuo-Hui Chang; Chun-Hsien Tseng; Karen M Frost; Ruth J Manvell; Dennis J Alexander
Journal:  Vet Microbiol       Date:  2004-11-30       Impact factor: 3.293

2.  Nucleotide sequence of the 5'-terminus of Newcastle disease virus and assembly of the complete genomic sequence: agreement with the "rule of six".

Authors:  R J Phillips; A C Samson; P T Emmerson
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

3.  A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity.

Authors:  Sweety Samal; Sachin Kumar; Sunil K Khattar; Siba K Samal
Journal:  J Gen Virol       Date:  2011-06-15       Impact factor: 3.891

4.  Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes.

Authors:  Diego G Diel; Luciana H A da Silva; Hualei Liu; Zhiliang Wang; Patti J Miller; Claudio L Afonso
Journal:  Infect Genet Evol       Date:  2012-08-07       Impact factor: 3.342

5.  Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan.

Authors:  L Yu; Z Wang; Y Jiang; L Chang; J Kwang
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

6.  Biological and phylogenetic characterization of a genotype VII Newcastle disease virus from Venezuela: efficacy of field vaccination.

Authors:  Francisco Perozo; Rosmar Marcano; Claudio L Afonso
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

7.  Detection and differentiation of velogenic and lentogenic Newcastle disease viruses using SYBR Green I real-time PCR with nucleocapsid gene-specific primers.

Authors:  Sheau Wei Tan; Aini Ideris; Abdul Rahman Omar; Khatijah Yusoff; Mohd Hair-Bejo
Journal:  J Virol Methods       Date:  2009-05-15       Impact factor: 2.014

8.  A longitudinal study of velogenic Newcastle disease virus genotypes isolated in Italy between 1960 and 2000.

Authors:  J Herczeg; S Pascucci; P Massi; M Luini; L Selli; I Capua; B Lomniczi
Journal:  Avian Pathol       Date:  2001-04       Impact factor: 3.378

9.  Molecular characterization of partial fusion gene and C-terminus extension length of haemagglutinin-neuraminidase gene of recently isolated Newcastle disease virus isolates in Malaysia.

Authors:  Ayalew Berhanu; Aini Ideris; Abdul R Omar; Mohd Hair Bejo
Journal:  Virol J       Date:  2010-08-08       Impact factor: 4.099

10.  Newcastle disease outbreaks in western China were caused by the genotypes VIIa and VIII.

Authors:  R Liang; D J Cao; J Q Li; J Chen; X Guo; F F Zhuang; M X Duan
Journal:  Vet Microbiol       Date:  2002-07-09       Impact factor: 3.293

View more
  6 in total

1.  Pathological and molecular investigation of velogenic viscerotropic Newcastle disease outbreak in a vaccinated chicken flocks.

Authors:  Asok Kumar Mariappan; Palanivelu Munusamy; Deepak Kumar; Shyma K Latheef; Shambu Dayal Singh; Rajendra Singh; Kuldeep Dhama
Journal:  Virusdisease       Date:  2018-04-03

2.  Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.

Authors:  Stivalis Cardenas-Garcia; Robert P Dunwoody; Valerie Marcano; Diego G Diel; Robert J Williams; Robert M Gogal; Corrie C Brown; Patti J Miller; Claudio L Afonso
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

3.  Phylogenetic and Pathotypic Characterization of Newcastle Disease Viruses Circulating in South China and Transmission in Different Birds.

Authors:  Yinfeng Kang; Bin Xiang; Runyu Yuan; Xiaqiong Zhao; Minsha Feng; Pei Gao; Yanling Li; Yulian Li; Zhangyong Ning; Tao Ren
Journal:  Front Microbiol       Date:  2016-02-09       Impact factor: 5.640

4.  Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.

Authors:  Jing Zhao; Huiming Yang; Hongjun Xu; Zengbin Ma; Guozhong Zhang
Journal:  Virol J       Date:  2017-03-16       Impact factor: 4.099

5.  Determinants of Newcastle disease in commercial layer chicken farms in two districts of Bangladesh: A case-control study.

Authors:  Shamsul Alam Roky; Moumita Das; Sharmin Akter; Aminul Islam; Suman Paul
Journal:  Heliyon       Date:  2022-08-13

6.  Efficacy of genotype-matched Newcastle disease virus vaccine formulated in carboxymethyl sago starch acid hydrogel in chickens vaccinated via different routes.

Authors:  Siti Nor Azizah Mahamud; Muhammad Bashir Bello; Aini Ideris; Abdul Rahman Omar
Journal:  J Vet Sci       Date:  2022-07       Impact factor: 1.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.